Loteprednol Etabonate recalls
Loteprednol Etabonate products have been recalled 1 time, most recently on 26 Jul 2023. The recalling company is usually SUN Pharmaceutical Industries. The most common reason is potency & assay.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 26 Jul 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why loteprednol etabonate is recalled
Companies
Product types
By year
All loteprednol etabonate recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%) recalledLoteprednol Etabonate | SUN Pharmaceutical Industries | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.